FDA approves Oxervate (cenegermin)

The US Food and Drug Administration (FDA) has approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease...

Australia adopts standards for ophthalmic nurses

The Australian Ophthalmic Nurses Association (AONA) National Council has launched the first National Practice Standards for Ophthalmic Nurses in Australia...

O=MEGA19 to become more mega?

Optometry Victoria (OV) and Optometry South Australia (OSA) members will vote on their proposed merger to become one representative optometry body at their...

EyeBall’s island of vision

Despite the chilly winter weather, the atmosphere was warm at the Grand Millennium at the end of July as the University of Auckland’s School of Optometry...

Disabled at heart of new funding model

A new disability support system, including a new funding model, will be trialled from 1 October in the MidCentral District Health Board (DHB).The new Enabling...

Jono: time for design

Australian eyewear designer Jono Hennessy Sceats, creator of popular Australasian brands, Jono Hennessy, Carter Bond and Zeffer, says the best thing about...

Alcon voluntarily withdraws CyPass Micro-Stent

Alcon has voluntarily withdrawn the CyPass Micro-Stent immediately, world-wide, and advises surgeons to stop implanting the CyPass Micro-Stent immediately...

Silmo Sydney 2018

The second Silmo Sydney was a quieter affair than its inaugural unveiling last year, with few of the major equipment and frames companies that were exhibiting...

Bottom Banner Advert